Jeena Sikho Lifecare (NSE:JSLL) Additional Paid-In Capital: ₹0 Mil(As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JSLL Jeena Sikho Lifecare Ltd NSE:JSLL
91 GF Score
Price ₹505.35
GF Value ₹804.91
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jeena Sikho Lifecare Additional Paid-In Capital?

Jeena Sikho Lifecare NSE:JSLL -0.17% 91 Additional Paid-In Capital is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹804.91 (Significantly Undervalued). The stock has 3 warning signs investors should review.


Jeena Sikho Lifecare's annual additional paid-in capital stayed the same from Mar. 2024 (₹533 Mil) to Mar. 2025 (₹533 Mil) but then declined from Mar. 2025 (₹533 Mil) to Mar. 2026 (₹0 Mil).

Jeena Sikho Lifecare Additional Paid-In Capital Related Terms

Jeena Sikho Lifecare Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for Jeena Sikho Lifecare's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeena Sikho Lifecare Additional Paid-In Capital Chart

Jeena Sikho Lifecare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Additional Paid-In Capital
Get a 7-Day Free Trial 15.08 533.08 533.08 533.08 0.00

Jeena Sikho Lifecare Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:JSLL
91GF Score
Jeena Sikho Lifecare Ltd NSE:JSLL
Additional Paid-In Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeena Sikho Lifecare Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of ₹0 Mil mean?
Jeena Sikho Lifecare (NSE:JSLL) has a Additional Paid-In Capital of ₹0 Mil as of Jun. 2026. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Jeena Sikho Lifecare and its competitors.
Is Jeena Sikho Lifecare's Additional Paid-In Capital too high?
Jeena Sikho Lifecare's current Additional Paid-In Capital is ₹0 Mil. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Additional Paid-In Capital compare to HCA and THC?
Jeena Sikho Lifecare's Additional Paid-In Capital of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Healthcare Providers & Services company?
A good Additional Paid-In Capital depends on the Healthcare Providers & Services industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Jeena Sikho Lifecare and its competitors. Jeena Sikho Lifecare's current Additional Paid-In Capital is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹804.91, compared to a current price of ₹505.35 — trading 37.2% below its estimated fair value. The current Additional Paid-In Capital is ₹0 Mil. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Additional Paid-In Capital is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?

Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued. The current stock price of ₹505.35 is trading 37.2% below its estimated GF Value™ of ₹804.91. GuruFocus considers Jeena Sikho Lifecare to be Significantly Undervalued.

Key valuation signals for NSE:JSLL:

  • Additional Paid-In Capital: ₹0 Mil
  • GF Value™: ₹804.91 vs. price of ₹505.35 (37.2% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jeena Sikho Lifecare Business Description

Other Exchanges 544476:India
Address Kalgidhar Enclave, SCO 11 First Floor, Mohali, Zirakpur, PB, IND, 140604
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score

Get the complete analysis for NSE:JSLL

Additional Paid-In Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹505.35
Price
₹804.91
GF Value